Candel Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Candel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.84M, a 151% increase year-over-year.
  • Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.51M, a 58.6% increase year-over-year.
  • Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.09M, a 34% increase from 2022.
  • Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.31M, a 22.1% decline from 2021.
  • Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.96M, a 40.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.51M $1.84M +$1.11M +151% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.4M $1.04M +$310K +42.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.09M $939K +$305K +48.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.79M $686K -$57K -7.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.84M $733K +$295K +67.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.55M $733K +$241K +49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.31M $634K +$1.08M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.23M $743K -$1.17M -61.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.39M $438K -$631K -59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.02M $492K +$61K +14.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.96M -$446K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.91M +$1.83M +2200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.07M +$766K +253% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $431K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $83K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $303K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.